300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Software
Legal
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Recruiting
Beauty
Fashion
Climate
Web3
LGBT
Medical
Cannabis
Celebrity
Theatre
Life Science
Music
Food and Beverage
Publishing
Art
Mobile Apps
Wine and Spirits
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Social Media
Digital Media
Franchise
Financial Services
Non Profit
Android
Internet
Mobile Advertising
Proptech
Impact
Enterprise
Sustainability
Hardware
Community
Biotech
Media (Entertainment)
Transportation
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Hong Kong
Nigeria
Zimbabwe
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Tunisia
Sweden
Oceania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Luxembourg
Marshall Islands
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Morocco
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Bangladesh
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Belize
Algeria
Bahamas
Italy
Belarus
Hungary
Finland
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Michelle Snyder, Partner at McKesson Ventures

Michelle Snyder

Partner @ McKesson Ventures

San Francisco, United States

Michelle Snyder is a Series B investor at McKesson Ventures in San Francisco focused on Health Care and Information Technology. Michelle Snyder - Partner @ McKesson Ventures

Total investments:
2
Last investment:
Lead investor:
50%

Last updated:

Industries Michelle Snyder invests in

Health CareInformation Technology

Stages Michelle Snyder invests in

Series B

Countries Michelle Snyder invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 2 (100%)
  • Information Technology 1 (50%)

Investments

CompanyDescriptionRoundLinks
Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industryluminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. $23M / Series B / Mar 05, 2025
Atropos Health rapidly provides personalized real-world evidence for any clinical decision $33M / Series B / May 23, 2024

Co-Investors

McKesson Ventures

About McKesson Ventures

VC Fund · San Francisco, United States

McKesson Ventures they help entrepreneurs in healthcare technology and services to create efficient health care delivery systems for key stakeholders on all sides of the health care economy.

McKesson Ventures Contacts

NameEmailPhoneSocials
Carrie Williams
Carrie Williams Vice President and Partner
Dave Schulte
Dave Schulte SVP, Managing Director
Ed Albrektsen
Ed Albrektsen Director, Vendor Solutions & Audit
Jennifer Carter
Jennifer Carter Vice President, Portfolio Development; Partner & Vice President Venture Operations
Michelle Snyder
Michelle Snyder Partner

Sign up to unlock verified contacts

Unlock Contacts

See all 7 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Software
Legal
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Recruiting
Beauty
Fashion
Climate
Web3
LGBT
Medical
Cannabis
Celebrity
Theatre
Life Science
Music
Food and Beverage
Publishing
Art
Mobile Apps
Wine and Spirits
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Social Media
Digital Media
Franchise
Financial Services
Non Profit
Android
Internet
Mobile Advertising
Proptech
Impact
Enterprise
Sustainability
Hardware
Community
Biotech
Media (Entertainment)
Transportation
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Hong Kong
Nigeria
Zimbabwe
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Tunisia
Sweden
Oceania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Luxembourg
Marshall Islands
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Morocco
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Bangladesh
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Belize
Algeria
Bahamas
Italy
Belarus
Hungary
Finland
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Michelle Snyder invest in?

Michelle Snyder invests primarily in Health Care and Information Technology startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Michelle Snyder?

Public channels for Michelle Snyder include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Michelle Snyder last invest?

The most recent investment recorded for Michelle Snyder closed in Mar 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Michelle Snyder Michelle Snyder Find email